1-866-877-2053 |
 |
The Hospice Clinician Blog
Search:
ABH Gel Acetaminophen acetaminophen acid suppression. ranitidine aclidinium bromide acute phosphate nephropathy adverse drug events Agitation albuterol aliskiren allergy alprazolam Alzheimer's Alzheimers Ambien Amitiza and Methadone (Dolophine) Angina anorexia antibiotics anticoagulation antiplatelet antipsychotic antipsychotics appetite Arcapta Neohaler Aricept arrhythmia aspirin asthma Ativan Avastin Avinza Azithromycin azithromycin Baclofen barbiturates Beers Criteria Beers List Benzodiazepines benzodiazepines bexarotene bone metastases bone pain Boniva bowel movement breakthrough pain Breo Ellipta brochodilator Buprenorphine BuprenorphinePranay Parihar cancer pain Cardiac Arrhythmia cardiovascular Celexa Chlorpromazine (Thorazine) Choosing Wisely Cimetidine Citalopram Citalopram (Celexa) CMS codeine colace Combivent Combivent Respimat compounded medication constipation controlled prescriptions controlled substance COPD Coronary Artery Disease corticosteroid Coumadin counterfeit drugs dabigatran Darvocet Darvon DEA Delirium dementia depression Diazepam docusate Doxepin drug disposal drug shortage drug shortages dry powder inhaler dyspnea Edluar Endo Endocet Endodan enema escitalopram Escitalopram (Lexapro) eszopiclone ethics Exalgo Exelon famotidine faxing prescriptions FDA FDA REMS fentanyl fentanyl sublingual spray first-generation antihistamines fleet enema flu vaccine Gastrointestinal generic generic Lexapro generic Seroquel generics H2RA haloperidol Haloperidol (Haldol) Heart Heart Failure hiccups hospice Hospice Action Network hospice advocacy hospice ceu hospice clinical hospice clinical support hospice compliance hospice Conditions of Participation hospice constipation hospice COP hospice CoP compliance hospice cough hospice docusate hospice drug hospice drug choice hospice drug disposal hospice drug dosage hospice drugs hospice drugs,delirium,haloperidol,haldol,antipsychotics hospice education hospice education programs hospice medication hospice medication disposal hospice medication orders hospice medication review hospice methadone hospice opioid conversion hospice opioids hospice pain management hospice patient hospice patient care hospice PBM hospice pbm hospice PBM choice hospice pharmacist hospice pharmacy hospice pharmacy benefit manager hospice pharmacy decision hospice seizure hospice symptom management hospira carpuject Hydrocodone hydrocodone hydrocodone/APAP hydrocodone/APAP recall hydromorphone hydromorphone recall hypoglycemics IBS incomplete cross-tolerance influenza inhaler inhaler technique INR insomnia Intermezzo ipratropium irritable bowel Kadian ketamine kidney disease laxative Lazanda leg cramps leukotriene-receptor antagonist Linaclotide Lipitor long acting opioids Lorazepam Lortab lovastatin drug interactions low dose aspirin LTRA Lubiprostone Lunesta lung cancer medical marijuana Medicare Part D medication adherence medication allergy medication disposal medication orders medication review medication shortage medication tapering Megace Meningitis meperidine metered dose inhaler Methadone methadone dosage Methylprednisolone methyphenidate Metoclopramide Midazolam morphine morphine injection recall morphine sulfate multiple sclerosis muscle relaxants naproxen narcotic nausea NHPCO Nitrate nitrofurantoin Nitroglycerin NSAID OIG olanzapine ondansetron hydrochloride Opana Opana ER opioid opioid allergy opioid disposal opioid induced constipation opioid-induced constipation opioids overactive bladder Oxybutynin Oxycodone oxycodone Oxycontin oxycontin oxymorphone oxytrol palliative care Parkinson's patient compliance PBM decision pediatric pediatric end of life care pediatric hospice pediatric hospice care pediatric palliative pediatric palliative care pediatric palliative symptom management Pepcid Percocet Percodan PPI Pradaxa Product Information Propoxyphene Prostate Cancer Proton Pump Inhibitor pruritis QT interval QT Prolongation quetiapine quinine Recall Reglan Relistor renal impairment research Revatio Risperidone risperidone Roflumilast Ropinirole Salonpas Sativex Schedule II schedule II medications scheduled medications Scopolamine sennosides Seroquel Silenor Singulair Sonata Spiriva Sprix START and STOPP statins liver function statins safety statins side effects stool softener stroke Sublingual Nitroglycerin subsys sulfa allergy Tagamet Targretin targretin TdP tertiary TCAs tiotropium TIRF REMS Access Program Transderm Scop transmucosal immediate-release fentanyl Tudorza Pressair Tylenol tylenol Valium Versed Vicodin vicodin vitamin K warfarin writing orders zaleplon Zantac zithromax Zofran zolpidem Zolpimist Zydone Zyprexa- Generic Versions of the Original Opana ER Will Continue to Be Manufactured
- Hospice Medication Alert: New Once Daily ICS/LABA for COPD
- Hospice Medication Alert: Vicodin® and Generic Substitution
- Faxing Schedule II Prescriptions to Pharmacies for Hospice Patients
- Lubiprostone (Amitiza®) Approved for Opioid-Induced Constipation: How should we use in hospice care?
- FDA Blocks Generic OxyContin: Implications for Hospice
- Join us at the NHPCO Management & Leadership Conference Next Week
- Drug Induced QT Prolongation and Cardiac Arrhythmia: Implications for Hospice Care
- OTC Treatment for Overactive Bladder
- Hospice Medication Alert: FDA Requires Lower Recommended Doses of Zolpidem
- Hospice Medication Alert: Changes of Acetaminophen Content in the Branded Vicodin Products
- DEA Proposes Regulations Expanding Options for Drug Disposal
- Hospice Medication Alert: Qualitest Recalls 101 Lots of Hydrocodone/APAP 10/500
- Hospice Medication Alert: Zofran 32 mg to be Pulled Due to Safety Concerns
- Pitfalls in the Management of Constipation in Hospice Patients
- NEJM Study: Relapse Risk After Discontinuation of Risperidone in Alzheimer’s Disease
- Hospice Medication Alert: FDA Opposes Hydrocodone/APAP Rescheduling
- Outcome Resources & NHPCO: Pediatric Palliative Care
- Hospice Medication Alert: Update on Fungal Meningitis Outbreak
- Palliative Care: The Best Language to Use with the Public
- FDA Reminds Prescribers About the Risks Associated with Using Quinine for Nocturnal Leg Cramps
- Study Reports that Docusate is Ineffective for Constipation in Hospice Patients
- Hospice Medication Alert: Methylprednisolone Recall Due to Meningitis Outbreak; 4 Deaths Recorded
- Review of DEA rules on Controlled Substance Prescriptions for Hospices
- Now Available: New Presentation on Pediatric Palliative Care
- The New Criteria for Potential Inappropriate Medications in Elderly - START and STOPP
- Hospice Medication Alert: New Combivent Formulation Coming This Month
- FDA Sued by Consumer Advocacy Group over Aricept 23 mg
- Should Hospice Patients use Exelon Patch?
- New Medication for Chronic Constipation and IBS: FDA Approves Linaclotide
- Pediatric Hospice Medication Alert: Recommendation Against Using Revatio in Children
- Hospice Medication Alert: EXALGO (Extended-Release Hydromorphone) 32mg Approved
- Bexarotene: Should Doctors Prescribe This Skin Cancer Drug for Alzheimer’s Disease?
- Congress Blames the FDA for Drug Shortages
- Reminder About the Risks of Using Codeine in Pediatric Palliative Care
- What is “Incomplete Cross-Tolerance”, and Why Does it Matter in Hospice?
- Pediatric Palliative Care: Strategies for Administering Medications
- The Age of "Digital Medicine" : Pill Sensor for Patient Adherence
- Should your hospice pay for leukotriene-receptor antagonists (LTRAs) for COPD patients?
- Hospice Medication Alert: New Long-Acting Inhaled Bronchodilator for COPD
- H2RAs and Delirium in Hospice Patients
- OIG Examines Medicare Medication Payments for Hospice Beneficiaries
- Hydrocodone-Containing Products May Become Schedule II Controlled Substances
- Abuse-Resistant OxyContin Pushes Users to Other Opioids, Including Heroin
- Hospice Medication Alert: Azithromycin and Risk of Cardiovascular Death
- Hospice Medication Alert: Morphine 20 mg/mL Patient Education Handout
- Update on REMS for Extended-Release and Long-Acting Opioids
- Hospice Medication Alert: Hospira Carpuject Pre-Filled Cartridges
- Rapid Treatment of Depression in Hospice, Part 2: Ketamine
- Haloperidol Dose Equivalence to Newer Atypical Antipsychotics
- Update on Injectable Lorazepam Shortage and Implications for Hospice
- Analgesics Reduce Agitation in Nursing Home Residents with Dementia
- Hospice Drug Alert - Hydromorhone Injection Recall
- Aspirin as Good as Warfarin in Heart Failure with Normal Sinus Rhythm
- Opioids for Dyspnea in COPD: Preferences of Patients, Caregivers and Prescribers
- Rapid Treatment of Depression in Hospice, Part 1: Methylphenidate
- Managing Elevated INRs in Patients Taking Warfarin
- New Hospice Drug: Intermezzo (Low-Dose Zolpidem)
- New Warnings and Contraindication for Aliskiren (Tekturna®)
- Morphine Injection Lot Recalled ? May Contain Excessive Fill Volume
- Disposal of Unused Medicines: What You Should Know
- The Four Medications that Cause 70% of Adverse-Event-Related Hospitalizations in Older Adults
- AAHPM Joins the Choosing Wisely® Campaign to Reduce Unnecessary Treatments
- Generic Seroquel® (Quetiapine) Now Available
- Updated Beers Criteria and Implications for Hospice Care, Part 3
- Updated Beers Criteria and Implications for Hospice Care, Part 2
- Updated Beers Criteria and Implications for Hospice Care, Part 1
- Generic Lexapro® Now Available
- Could a Skin Cancer Drug Be the Cure for Alzheimer's Disease?
- Statins - Important Safety Label Changes
- Hospice Medication Alert: Fleet Enemas and Acute Renal Failure
- Midazolam Via Intramuscular Autoinjector For Seizure Treatment
- Counterfeit Version of Avastin (bevacizumab) in Circulation in the US
- How to Dose Immediate-Release Opioids for Breakthrough Pain in Hospice Patients
- Hospice Drug Safety Alert: PPIs Associated with C. Difficile Diarrhea
- "Drug Shortage Prevention Act" Introduced
- Make This YOUR Hospice Pharmacy Blog by Providing Your Ideas and Feedback!
- Medication Reviews and Medicare CoPs: Is Your Hospice in Compliance?
- Proper Inhaler Technique in Hospice Patients
- Update on Immediate-Release Fentanyl REMS
- Hospice Medication Alert: New Fentanyl Sublingual Spray Approved
- Attention Hospice Providers: Important Public Health Advisory
- Hospice Medication Alert: Washington State Warns on Methadone Use
- Hospice Medication Update: Morphine/Oxycodone Combination Product (MoxDuo® IR) Expected in 2012
- Study Suggests Synergism Between Medical Marijuana and Opiates
- Hospice Medication Alert: Oral Relistor® Tablets in the Pipeline
- Hospice Drug Shortage: Oxycodone Immediate-Release Tablets & Capsules
- How to Choose an NSAID for Hospice Patients, Part 3
- Lorazepam Injection Shortage: Implications for Hospice
- How to Choose an NSAID for Hospice Patients, Part 2
- How to Choose an NSAID for Hospice Patients, Part 1
- Hospice Medication Alert: Pradaxa® Under FDA Investigation
- Researchers Block Morphine-Induced Pruritis
- Lipitor® Off Patent Today
- Updated Beers Criteria on the Way
- Opioid Allergy versus Pseudoallergy: How to Differentiate
- Hospice Medication Alert: Scopolamine Patch Shortage
- Hospice Medication Alert: Kadian® and Avinza®
- Generic olanzapine available, but not much cheaper than Zyprexa
- Is Nitrate Tolerance Important in Hospice Patients?
- When and How to Taper Oral Corticosteroids in Hospice Patients
- Writing a Proper Medication Order for Hospice Patients, Part 3: Things to Avoid
- Writing a Proper Medication Order for Hospice Patients, Part 2: PRN Meds
- Writing a Proper Medication Order for Hospice Patients, Part 1: Scheduled Meds
- Boniva vs. Radiation for Bone Pain in Prostate Cancer Patients
- Hospice Medication Alert: Ingredients in ABH Gel Not Absorbed
- Prophylactic Antibiotic Therapy: Implications for Hospice Patients with Severe COPD
- Hospice Medication Alert: Maximum Daily Dose of Tylenol Reduced
- Medical Marijuana Dispensaries are Now at Risk for DEA Raids
- Hospice Medication Alert: High-dose Citalopram (Celexa)
- Revised Seroquel Label: Stronger Warnings
- Update on Opioid Risk Evaluation and Mitigation Strategies
- Hospice, End Stage Dementia, & The Role of Drug Treatment PART 2
- Hospice, End Stage Dementia, & the Role of Drug Treatment PART 1
- Hospice Medication Update: Morphine/Oxycodone Combination Product
- Hospice Medication Alert: Arcapta Neohaler for COPD
- Hospice Medication Alert: Fentanyl Nasal Spray Approved by FDA
- Pediatric Palliative Care: Pediatric Acetaminophen Concentration & Dosing
- Risk of Hospice Medication Errors: Ropinirole (Requip) and Risperidone (Risperdal)
- Hospice Medication Alert: New Drug for Insomnia: Silenor (Doxepin)
- Hospice Clinicians: Roflumilast (Daliresp®) Approved by the FDA for COPD
- New Study Shows Cannabis Extract Sativex Effective for MS, in trials for Cancer Pain
- Hospice Advocacy & The 26th NHPCO MLC
- Hospice Medication Alert: New COPD Drug Approved by the FDA
- Medication Mangement of Delirium in Hospice Patients
- Hospice Medication Update: New Limits on Acetaminophen Content in Opioid/APAP Combination Products
- Identifying Causes of Delirium in Hospice Patients
- Reglan (Metoclopramide) and Tardive Dyskinesia in Hospice Patients
- Hospice Medication Alert: Withdrawal of Propoxyphene from the Market
- Hospice Patients and the Flu Vaccine
- Hospice Medication Update: Oxycodone 20mg/ml Oral Concentrate Shortage
- Hospice Medication Update: Exalgo (Hydromorphone, Opioid)
- The Use of Megestrol Acetate (Megace) in Elderly Hospice Patients
- Upcoming Presentation by Dr. Jim Joyner, PharmD
- Early Initiation of Palliative Care May Increase Survival in Lung Cancer Patients
- Hospice Medication Update: Oxycodone Oral Solution Availability
- High-Dose Donepezil Approved for Moderate to Severe Alzheimer's Disease
- Pediatric Palliative Symptom Management
- New Hospice Medication Update: Butrans
- FDA Approves Generic Fentora and Generic Effexor XR
- Series on Pediatric Hospice & Palliative Care Patients
- Pediatric Palliative Care: Pain Management
- Pain Management in Hospice Patients: Buprenorphine (Subutex, Suboxone)
- Proton Pump Inhibitors and Hospice Patients
- New FDA Approvals of Pain Medications for Hospice Patients
- Revised Labeling & Warnings for Hospice Medications
- Proper Use of Sublingual Nitroglycerin
- Generic Memantine for Alzheimer's Approved by the FDA
- Opioid Medication Shortages in Hospice Care
- Methadone in Hospice and Palliative Care
- New OxyContin Formulation and Generic Alprazolam Approved
- Hospice Advocacy: Outcome Resources goes to Washington!
- Find out more about Pharmacy Services for your Hospice at the NHPCO MLC!
- Pediatric Palliative Care: Current Concepts in Drug Therapy
- Baclofen: Effective for Cancer Pain in Hospice Patients
- DEA Actions May Compromise Hospice Patients in Nursing Homes - UPDATE
- Relistor for Opioid Induced Constipation in Hospice Patients
- Nebulized Opioids for Hospice Patients
- Federal Hospice Conditions of Participation: The Comprehensive Drug Review
- Sativex for Hospice Patients?
- What is a Pharmacy Benefit Manager? How can a PBM benefit my hospice?
- Is there a less expensive therapeutic alternative for Xopenex?
- Drug Disposal in Hospice Care: FDA Guidelines
- Discontinuing Drugs in Hospice: Which ones need to be tapered? Part 2
- Discontinuing Drugs in Hospice: Which ones need to be tapered? (Part 1)
- Phenytoin (Dilantin) Rectal Administration in Hospice Patients
- What Drugs Work for a Hospice Patient with Hiccups?
- Appetite Stimulation in Hospice Patients
- Morphine and Renal Impairment in Hospice Patients
- Hospice Patients with Sulfa Allergy
- Drugs for Treatment of Cough in the Hospice Patient
- Pain Management in Hospice Patients: Onsolis
- Opioid Induced Pain in Hospice Patients: Hyperalgesia and Allodynia
- Pain Management in Hospice Patients: The Fentanyl Patch
- Dementia Drug Alert for Hospices
- Hospices, Opioids, & the FDA REMS
- Tips for Choosing a Pharmacy Benefit Manager for your Hospice PART 2
- Tips for Choosing a Pharmacy Benefit Manager for your Hospice PART 1
- Methadone for Hospice Patients Part 2
- Methadone for Hospice Patients Part 1
- Pain Management in Hospice Patients: Reactions to Opioids
2013 Articles
2012 Articles
2011 Articles
2010 Articles
2009 Articles
09/17/2010
Upcoming Presentation by Dr. Jim Joyner, PharmD
Dr. Jim Joyner, Pharm.D., Director of Clinical Operations for Outcome Resources, will be providing a clinical presentation at the upcoming 34th Annual Conference of The Carolinas Center for Hospice and End of Life Care on October 6th in Myrtle Beach, South Carolina. The title of the presentation is “Medication Management of Delirium and Chronic Agitation in the Hospice Patient." This presentation will explore delirium in the hospice patient and the relationship to medication from both a treatment perspective and as a possible cause for the condition.
For more information and to register for the Conference, contact The Carolinas Center for Hospice & End of Life Care.
"
Tags: hospice, hospice symptom management, palliative care
| First 10 | <<Previous 10 | Next 10 >> | Last 10 |
Education Resources and Support for HospicesStay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or via |
 |
|
Why Use A PBM?Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There’s an easier and more effective way. Find out how using a pharmacy benefits manager (PBM) can help you>>
|
teleconference, online service education programs, customized courses, and courses accredited for nursing continuing education credit.
